Your browser doesn't support javascript.
loading
The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans.
Ferdinand, Keith C; Nedunchezhian, Saihariharan; Reddy, Tina K.
Affiliation
  • Ferdinand KC; Tulane University School of Medicine, New Orleans, LA, USA. Electronic address: kferdina@tulane.edu.
  • Nedunchezhian S; Tulane University School of Medicine, New Orleans, LA, USA.
  • Reddy TK; Tulane University School of Medicine, New Orleans, LA, USA.
J Natl Med Assoc ; 112(6): 681-687, 2020 Dec.
Article de En | MEDLINE | ID: mdl-33276969
Influenza is a contagious respiratory virus that causes a significant annual health burden in the United States (US). In spite of effective yearly vaccinations to protect individuals against influenza-related health complications, especially with certain chronic co-morbid illnesses, persistent racial/ethnic disparities exist in influenza immunization. African Americans continue to experience low vaccination uptake, stemming, at least in part, from years of bias in and mistrust of orthodox medicine, safety concerns, and environmental barriers to vaccine access. The novel respiratory coronavirus, SARS-CoV2, causes COVID-19, leading to a pandemic that in the U.S. has exerted severe physical, psychological, and economic tolls on the African Americans and other disadvantaged communities. These two respiratory-borne virus' cause disparate effects in the black community, unmasking persistent disparities in healthcare. Unfortunately, suboptimal influenza immunization acceptance exacerbates flu-related adverse health outcomes, similar to difficulties from the effects of the COVID-19 pandemic. In consideration of the impending influenza-COVID-19 "twindemic", robust educational campaigns, policy initiatives, and novel approaches to influenza immunization must be considered for the African American community to build trust in the health benefits of the influenza vaccination and, ultimately, to trust in the health benefits of potential SARS-CoV2 vaccines, when available for the general public.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Services de médecine préventive / 1766 / Vaccins antigrippaux / Grippe humaine / Amélioration de la qualité / Vaccins contre la COVID-19 / COVID-19 Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: J Natl Med Assoc Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Services de médecine préventive / 1766 / Vaccins antigrippaux / Grippe humaine / Amélioration de la qualité / Vaccins contre la COVID-19 / COVID-19 Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: J Natl Med Assoc Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique